Post-Craniopharyngioma and Cranial Nerve-VI Palsy Update on a MS Patient with Major Depression and Concurrent Neuroimmune Conditions

Brain Sci. 2019 Oct 17;9(10):281. doi: 10.3390/brainsci9100281.


We report the case of a male multiple sclerosis (MS) patient with type 2 diabetes (T2D), asthma, major depression (MD or major depressive disorder, MDD), and other chronic conditions, after his recent difficulties with craniopharyngioma and cranial nerve-VI (CN6) palsy. In addition, we show magnetic resonance image and spectroscopy (MRI, MRS), Humphrey's Visual Field (HVF), and retinal nerve fiber layer thickness (RNFLT) findings to explain the changes in the patient's health, and discuss the methods that helped/help him sustain productivity and euthymia despite long-standing problems and new CNS changes.

Keywords: S-adenosylmethionine; bupropion; cranial nerve-VI palsy; craniopharyngioma; fractionated stereotactic radiation treatments; major depression; multiple sclerosis; sphenoid sinusitis; vitamin D3; yoga.

Publication types

  • Case Reports